Recent Updates
Recently added Catalysts
LH Positive Sentiment

Document FOR IMMEDIATE RELEASE Labcorp Contacts Investors Christin O'Donnell - 336-436-5076 Investor Labcorp.com Media Kimbrel Arculeo - 336-436-8263 Media Labcorp.com

Thursday, July 25, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Labcorp announced a cash dividend of $0.72 per share to be paid on September 13, 2024, to shareholders recorded by August 29, 2024. This announcement underscores the company’s financial health and commitment to returning capital to its shareholders. Labcorp is recognized for its pioneering laboratory services, which significantly contribute to the pharmaceutical industry and healthcare at large. The organization has a notable workforce and has supported a large number of new drug approvals in recent years.
Price reaction · baseline $209.49 (2024-07-24 close) · hit after-hours · clean, no other LH news in the window
day 0 close
+0.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Labcorp declared a quarterly dividend of $0.72 per share, indicating financial stability and shareholder returns.
  • The company plays a significant role in supporting new drug approvals, having aided 84% of new drugs approved in 2023.
  • Labcorp's workforce of over 67,000 employees reflects a strong operational capacity to support global clients.

Full Press Release Details

Investors Christin O'Donnell - 336-436-5076
Investor Labcorp.com
Media Kimbrel Arculeo - 336-436-8263
LABCORP DECLARES QUARTERLY DIVIDEND
BURLINGTON, N.C., July 25, 2024 - Labcorp (NYSE LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 13, 2024, to stockholders of record as of the close of business on August 29, 2024.
Labcorp (NYSE LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA, and performed more than 600 million tests for patients around the world. Learn more about us at www.labcorp.com.

Frequently Asked Questions

What is the amount of Labcorp's declared quarterly dividend?

Labcorp has declared a cash dividend of $0.72 per share.

When will Labcorp's dividend be payable?

The dividend will be payable on September 13, 2024.

What is the record date for Labcorp's dividend?

The record date for the dividend is August 29, 2024.

How many tests did Labcorp perform globally?

Labcorp performed over 600 million tests globally.

In how many countries does Labcorp serve clients?

Labcorp serves clients in approximately 100 countries.

ShareAdd on Google
Tags: LH Viatris Investor Conferences Healthcare Labcorp dividend NYSE LH FDA approvals laboratory services
Last updated: Jul 25, 2024

Biotech snapshot

Cash runway
$352M liquidity · $0M/mo burn
Low dilution risk